June 1 (Reuters) - Mauna Kea Technologies Sas MKEA.PA :
* MAUNA KEA TECHNOLOGIES ANNOUNCES START OF ENROLLMENT IN
PERIPHERAL LUNG CANCER MULTI-SITE CLINICAL TRIAL COMBINING ION®
WITH CELLVIZIO®
* ANNOUNCES START OF ENROLLMENT IN PERIPHERAL LUNG CANCER
MULTI-SITE CLINICAL TRIAL COMBINING ION® WITH CELLVIZIO®
* INITIAL ENROLLMENT OF PATIENTS HAS BEGUN IN A PROSPECTIVE,
RANDOMIZED, TWO-ARM, MULTI-SITE CLINICAL STUDY SPONSORED BY MAYO
CLINIC AND FINANCIALLY SUPPORTED BY MAUNA KEA TECHNOLOGIES.
Source text for Eikon: ID:nBw5cpWYba
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))